Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jan;61(1):7–8. doi: 10.1038/bjc.1990.3

Clinical aspects of early stage non-Hodgkin's lymphoma.

G M Mead 1
PMCID: PMC1971314  PMID: 2404510

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson T., Chabner B. A., Young R. C., Berard C. W., Garvin A. J., Simon R. M., DeVita V. T., Jr Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer. 1982 Dec 15;50(12):2699–2707. doi: 10.1002/1097-0142(19821215)50:12<2699::aid-cncr2820501202>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  2. Armitage J. O., Wen B. C. Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 1987 Sep;13(9):1351–1354. doi: 10.1016/0360-3016(87)90228-8. [DOI] [PubMed] [Google Scholar]
  3. Cabanillas F. Chemotherapy as definitive treatment of stage I-II large cell and diffuse mixed lymphomas. Hematol Oncol. 1985 Jan-Mar;3(1):25–31. doi: 10.1002/hon.2900030104. [DOI] [PubMed] [Google Scholar]
  4. Castellino R. A., Dunnick N. R., Goffinet D. R., Rosenberg S. R., Kaplan H. S. Predictive value of lymphography for sites of subdiaphragmatic disease encountered at staging laparotomy in newly diagnosed Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol. 1983 Sep;1(9):532–536. doi: 10.1200/JCO.1983.1.9.532. [DOI] [PubMed] [Google Scholar]
  5. Connors J. M., Klimo P., Fairey R. N., Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med. 1987 Jul;107(1):25–30. doi: 10.7326/0003-4819-107-1-25. [DOI] [PubMed] [Google Scholar]
  6. Fuks Z., Kaplan H. S. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology. 1973 Sep;108(3):675–684. doi: 10.1148/108.3.675. [DOI] [PubMed] [Google Scholar]
  7. Glatein E., Donaldson S. S., Rosenberg S. A., Kaplan H. S. Combined modality therapy in malignant lymphomas. Cancer Treat Rep. 1977 Sep;61(6):1199–1207. [PubMed] [Google Scholar]
  8. Goffinet D. R., Warnke R., Dunnick N. R., Castellino R., Glatstein E., Nelsen T. S., Dorfman R. F., Rosenberg S. A., Kaplan H. S. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):981–992. [PubMed] [Google Scholar]
  9. Gospodarowicz M. K., Bush R. S., Brown T. C., Chua T. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):489–497. doi: 10.1016/0360-3016(84)90028-2. [DOI] [PubMed] [Google Scholar]
  10. Horwich A., Catton C. N., Quigley M., Easton D., Brada M. The management of early-stage aggressive non-Hodgkin's lymphoma. Hematol Oncol. 1988 Oct-Dec;6(4):291–298. doi: 10.1002/hon.2900060404. [DOI] [PubMed] [Google Scholar]
  11. Kaminski M. S., Coleman C. N., Colby T. V., Cox R. S., Rosenberg S. A. Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med. 1986 Jun;104(6):747–756. doi: 10.7326/0003-4819-104-6-747. [DOI] [PubMed] [Google Scholar]
  12. Kantarjian H. M., McLaughlin P., Fuller L. M., Dixon D. O., Osborne B. M., Cabanillas F. F. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients. J Clin Oncol. 1984 Jul;2(7):811–819. doi: 10.1200/JCO.1984.2.7.811. [DOI] [PubMed] [Google Scholar]
  13. Lawrence T. S., Urba W. J., Steinberg S. M., Sundeen J. T., Cossman J., Young R. C., Glatstein E. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. Int J Radiat Oncol Biol Phys. 1988 Mar;14(3):417–424. doi: 10.1016/0360-3016(88)90254-4. [DOI] [PubMed] [Google Scholar]
  14. Levitt S. H., Lee C. K., Bloomfield C. D., Frizzera G. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol. 1985 Jan-Mar;3(1):33–37. doi: 10.1002/hon.2900030105. [DOI] [PubMed] [Google Scholar]
  15. Mackintosh J. F., Cowan R. A., Jones M., Harris M., Deakin D. P., Crowther D. Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1617–1622. doi: 10.1016/0277-5379(88)90054-5. [DOI] [PubMed] [Google Scholar]
  16. Mauch P., Leonard R., Skarin A., Rosenthal D., Come S., Chaffey J., Hellman S., Canellos G. Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol. 1985 Oct;3(10):1301–1308. doi: 10.1200/JCO.1985.3.10.1301. [DOI] [PubMed] [Google Scholar]
  17. McLaughlin P., Fuller L. M., Velasquez W. S., Sullivan-Halley J. A., Butler J. J., Cabanillas F. Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer. 1986 Oct 15;58(8):1596–1602. doi: 10.1002/1097-0142(19861015)58:8<1596::aid-cncr2820580803>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  18. Miller T. P., Jones S. E. Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood. 1983 Aug;62(2):413–418. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES